Charmacy Pharmaceutical Co., Ltd. (2289.HK)
- Previous Close
7.750 - Open
7.750 - Bid --
- Ask 7.750 x --
- Day's Range
7.750 - 7.750 - 52 Week Range
6.810 - 14.400 - Volume
13,500 - Avg. Volume
767 - Market Cap (intraday)
837M - Beta (5Y Monthly) -0.71
- PE Ratio (TTM)
14.62 - EPS (TTM)
0.530 - Earnings Date Mar 28, 2025
- Forward Dividend & Yield 0.48 (6.18%)
- Ex-Dividend Date May 26, 2025
- 1y Target Est
--
Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People's Republic of China. The company distributes western medicines, Chinese patent medicines, healthcare products, and related pharmaceutical products consulting services to downstream distributors and retail terminals. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquires and payments, etc. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is based in Shantou, the People's Republic of China.
www.chmyy.com847
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2289.HK
View MorePerformance Overview: 2289.HK
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2289.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2289.HK
View MoreValuation Measures
Market Cap
837.00M
Enterprise Value
2.05B
Trailing P/E
14.63
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.18
Price/Book (mrq)
1.26
Enterprise Value/Revenue
0.43
Enterprise Value/EBITDA
11.46
Financial Highlights
Profitability and Income Statement
Profit Margin
1.20%
Return on Assets (ttm)
2.52%
Return on Equity (ttm)
8.76%
Revenue (ttm)
4.44B
Net Income Avi to Common (ttm)
53.28M
Diluted EPS (ttm)
0.530
Balance Sheet and Cash Flow
Total Cash (mrq)
573.86M
Total Debt/Equity (mrq)
227.81%
Levered Free Cash Flow (ttm)
-69.75M